Osmotic Laxative Market Size & Share, by Product (Lactulose, Sorbitol, Magnesium Citrate, Milk of Magnesium, Polyethylene Glycol); Application (Drug Store, Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5378
  • Published Date: Nov 16, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Osmotic Laxative Market size is poised to reach USD 16 billion by the end of 2036, expanding around 7% CAGR during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of osmotic laxative was over USD 7 billion. The growth of the market is set to rise on account of the increasing prevalence of eating disorder. In 2023, the prevalence of eating disorders worldwide rose from about 2% to approximately 8%. Hence, the demand for osmotic laxative is estimated to grow since binge eating cause food digest slowly and with the use of osmotic laxative this process becomes smooth.

Moreover, the market's assortment of products can be made more diverse with the launch of novel osmotic laxatives. Customers may have exposure to a greater selection of possibilities as a result, including goods that might better fit their requirements and tastes. New laxative products may be developed as a consequence of increased R&D efforts. In order to develop laxatives that are more effective and bearable, researchers may investigate innovative formulations, delivery systems, and mechanisms of action. Hence, with this, the osmotic laxative market revenue for osmotic laxatives is projected to rise.

Osmotic Laxative Market
Get more information on this report: Request Free Sample PDF

Osmotic Laxative Market: Growth Drivers and Challenges

Growth Drivers

  • Rising Geriatric Population- One in six people on the globe is going to be 60 years of age or older by 2030. At this point, there are expected to be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of individuals in the entire globe who are 60 years of age or older is expected to double (to 2.1 billion) by 2050. Since digestive issues are more common in the elderly population, this group of people has a big influence on the osmotic laxative market. Elderly people are more inclined to experience constipation, which may be caused by several factors including decreased mobility, medication use, and age-related changes in bowel function. The elderly population has a greater need for osmotic laxative products as a result

  • Lack of Significant Physical Activity- A lack of exercise among people is becoming a significant public health issue leading to several chronic health conditions. Moreover, people who exercise frequently typically do not suffer from constipation, as the colon reacts, in essence, to movement. Regular bowel movements often depend on a healthy muscular tone. During the bowel movement process, the diaphragm and the muscles of the abdominal wall are very important. These muscles may not be able to perform the job if they are weak.
  • Growth in Healthcare Infrastructure - An improved infrastructure for healthcare frequently results in a greater understanding of gastrointestinal disorders, such as constipation, and improved diagnostic capabilities. This may lead to an increase in the number of people obtaining medical attention for these conditions, which could raise the need for laxatives. Telemedicine and telehealth solutions may be included in an expanding healthcare infrastructure to facilitate patient access to medical advice and treatment recommendations for digestive health issues. This may result in the more intelligent use of osmotic laxatives.


  • Stringent Regulation & Guidance
  • Lack of Access to Service - The identification and management of gastrointestinal diseases requiring prescriptions for osmotic laxatives may be delayed as a result of the lack of qualified doctors. This may take longer for patients to get the proper medical care after they start exhibiting symptoms. Creating thorough treatment programmes for patients with gastrointestinal problems is the responsibility of qualified specialists. Lack of these specialists could lead to less-than-ideal treatment regimens, which would affect osmotic laxative therapy's efficacy.
  • High Price of Drug Development - It is costly for researchers to create new medications since it requires a lot of research, clinical studies, and regulatory compliance, whether the pills are osmotic laxatives or something else entirely. Attempting to raise prices in order to recover investment expenditures may result from these high development costs. This can result in increased costs for recently created osmotic laxative products on the osmotic laxative market. Hence, this element is predicted to hinder the expansion of the market.

Osmotic Laxative Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

~ USD 7 Billion

Forecast Year Market Size (2036)

~ USD 16 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Osmotic Laxative Segmentation

Indication (Chronic Constipation, Irritable Bowel Syndrome with Constipation, Opioid-Induced Constipation, Acute Constipation)

The chronic constipation segment is projected to account for 40% share of the global osmotic laxative market by 2036. The growth of the segment is set to grow on account of the rising prevalence of diverticulosis. In the West, it is typical, particularly as one gets older. Diverticulosis impacts about 29% of adults over 50, approximately 49% of adults over 60, and over 74% of adults over 80 in the United States. The most widely recognized explanation for how diverticulosis forms has to do with elevated colonic pressure, which pushes weak points in the colon wall to protrude and create sacs. Another factor could be a diet heavy in red meat and poor in fiber. This further increases the cases of constipation. Hence, this has increased the demand for osmotic laxatives.

Application (Drug Store, Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

The online pharmacies segment in the osmotic laxative market is poised to hold 50%  of the revenue share during the coming years. The major element for the growth of the market is the rising demand for medication online. Moreover, purchasing medications online saves money. Online medicine purchases may result in total cost savings of up to approximately 32%, based on studies. E-pharmacy also provides the benefit of privacy and secrecy. Patients benefit greatly from e-pharmacies, since they offer a far greater selection of options than traditional pharmacies. There are many more drug possibilities available in regular drug stores, however, not every drug can be found in a physical pharmacy in a particular area. Hence, the segment is observing significant growth in its expansion.

Our in-depth analysis of the global osmotic laxative market includes the following segments:



  • Lactulose
  • Sorbitol
  • Magnesium Citrate
  • Milk of Magnesium
  • Polyethylene Glycol



  • Drug Store
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies



  • Chronic Constipation
  • Irritable Bowel Syndrome with Constipation
  • Opioid-Induced Constipation
  • Acute Constipation

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Osmotic Laxative Industry- Regional Synopsis

North American Market Forecast

The North America osmotic laxative market is estimated rise by gathering share of about 40% over the forecast period. The growth of the market in this region is projected to be influenced by rising prevalence of gastrointestinal. There are about 59–70 million Americans who suffer from gastrointestinal (GI) disorders, many of which are only detectable by a medical practitioner and may seriously disrupt with day-to-day functioning. Additionally, the increasing abusing of alcohol in this region is also predicted to cause huge disruption in digestive process. As a result, the market expansion in this region is set to grow over the coming years.

European Market Analysis

The Europe osmotic laxative market is also expected to have notable growth during the forecast period. This growth could be dominated by rising constipation issues in this region on account of growing consumption of unhealthy food. A survey conducted in early 2021 in the UK and Belgium revealed that around 4 times a month, people there were eating junk food. Additionally, despite a number of encouraging recent national initiatives, including those in Spain and the United Kingdom, European nations and the EU are still not able to fully and successfully address the issue of children being exposed to unhealthy food marketing. Hence, the consumption of unhealthy food is growing in the region which is further influencing cases of constipation.

Research Nester
Osmotic Laxative Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Osmotic Laxative Market

    • GlaxoSmithKline
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bayer AG
    • Pfizer Inc.
    • Sanofi
    • Johnson & Johnson Private Limited
    • Novartis AG
    • Procter & Gamble
    • Reckitt Benckiser Group PLC
    • Boehringer Ingelheim International GmbH
    • AstraZeneca

In the News

  • Together, Bayer AG and Peking University (PKU) will accelerate scientific research on cutting-edge technologies throughout the pharmaceutical value chain and support the translation of fundamental pharmaceutical research into drug discovery and development.
  • The U.S. subsidiary of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals, and Sanofi have announced a partnership to co-develop and co-commercialize asset TEV’574, which is presently undergoing Phase 2b clinical trials for the treatment of Crohn’s disease and ulcerative colitis, two forms of inflammatory bowel disease.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5378
  • Published Date: Nov 16, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are rising geriatric population, surge in prevalence of constipation, and growth in healthcare infrastructure.

The market size of osmotic laxative is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market are GlaxoSmithKline, Bayer AG, Pfizer Inc., Sanofi, and others.

The chronic constipation segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Osmotic Laxative Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying